Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | MRGPRX1 | Q96LB2 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13815234 | 0.91 | MAPT (0.33) | MAPTTSHRCYP2A6KDM4ENPC1 | |
| SCHEMBL25831616 | 0.90 | MAPT (0.35) | MAPTTSHRCYP2A6KDM4ENPC1 | |
| SCHEMBL18133632 | 0.86 | CSNK2A1 (0.33) | MAPTTSHRCYP2A6KDM4ENPC1 | |
| SCHEMBL12275227 | 0.79 | DYRK1A (0.33) | MAPTTSHRCYP2A6DYRK1A | |
| SCHEMBL2742950 | 0.75 | DYRK1A (0.37) | CYP2A6KDM4EDYRK1A | |
| SCHEMBL22504301 | 0.75 | MAPT (0.36) | MAPTTSHRCYP2A6KDM4ECYP1A2 | |
| SCHEMBL26080844 | 0.75 | KDM4E (0.42) | MAPTTSHRCYP2A6KDM4EALDH1A1 | |
| SCHEMBL13280423 | 0.74 | PARP1 (0.33) | MAPTTSHRDYRK1A | |
| SCHEMBL21414006 | 0.73 | MAPT (0.35) | MAPTTSHRKDM4EALDH1A1GAA | |
| SCHEMBL6127813 | 0.72 | CYP1A2 (0.39) | MAPTTSHRCYP2A6KDM4ECYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9184390-B2 | Polymers with tunable band gaps for photonic and electronic applications | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2015-11-10 | — | — | US | disclosed |
| US-20130092912-A1 | POLYMERS WITH TUNABLE BAND GAPS FOR PHOTONIC AND ELECTRONIC APPLICATIONS | NAVY, SECRETARY OF THE UNITED STATES OF AMERICA | 2013-04-18 | — | — | US | disclosed |
| WO-2011156478-A2 | POLYMERS WITH TUNABLE BAND GAPS FOR PHOTONIC AND ELECTRONIC APPLICATIONS | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2011-12-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130092912-A1 | POLYMERS WITH TUNABLE BAND GAPS FOR PHOTONIC AND ELECTRONIC APPLICATIONS | GJB2, PARG, PARN | MAPT 2075/4885TSHR 4836/4885CYP2A6 2410/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.